The role of protein phosphorylation in human health and disease: Delivered on June 30th 2001 at the FEBS meeting in Lisbon

European Journal of Biochemistry

Volumn 268, Issue 19, 2001, Pages 5001-5010

  Cohen, Philip ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Cancer; Diabetes; Drugs; GSK3; Inflammation; Phosphorylation; Protein kinase; Signal transduction; Wnt

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE; 2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID; 3 [(4,5 DIMETHYL 1H PYRROL 2 YL)METHYLENE] 1,3 DIHYDRO 2H INDOL 2 ONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTIDIABETIC AGENT; CANERTINIB; CYCLOSPORIN; ERLOTINIB; GEFITINIB; IMATINIB; N (4 BROMO 2 FLUOROPHENYL) 6 METHOXY 7 [2 (1H 1,2,3 TRIAZOL 1 YL)ETHOXY] 4 QUINAZOLINAMINE; PROTEIN; PROTEIN GSK3; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE INHIBITOR; RAPAMYCIN; TACROLIMUS; UNCLASSIFIED DRUG; VANDETANIB; VATALANIB;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER; CARCINOGENICITY; CLINICAL TRIAL; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME REGULATION; ENZYME SPECIFICITY; HEALTH; HUMAN; INFLAMMATORY DISEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STROKE; UNIVERSITY;

CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; ENZYME INHIBITORS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INFLAMMATION; NEOPLASMS; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEINS; SIGNAL TRANSDUCTION;

EID: 0034797512     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0014-2956.2001.02473.x     Document Type: Article

References (50)

1. Protein tyrosine phosphatase activity of an essential virulence determinant of Yersinia
2. Okadaic acid: A new probe for the study of cellular regulation
3. Cyanobacterial microcystin-LR is a potent and specific inhibitor of protein phosphatases 1 and 2A from both mammals and higher plants
4. Fatal microcystin intoxication in a haemodialysis unit in Caruaru, Brazil
5. The toxins of cyanobacteria
6. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
7. 80)
8. From oncogene to drug: Development of small molecule tyrosine kinase inhibitors as anti-tumor and anti-angiogenic agents
9. A synthetic inhibitor of the mitogen-activated protein kinase cascade
10. PD 98059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
11. Specificity and mechanism of action of some commonly used protein kinase inhibitors
12. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
13. Small molecule modulators of cyclin-dependent protein kinases for cancer therapy
14. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases
15. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function
16. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
17. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins
18. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stress and interleukin-1
19. MAPKAP kinase 2 is essential for LPS-induced TNF-a biosynthesis
20. The search for physiological substrates of MAP and SAP kinases in mammalian cells
21. The tenth Datta lecture; PDK1, one of the missing links in insulin signal transduction?
22. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα
23. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
24. Glycogen synthase kinase-3 from rabbit skeletal muscle; separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase
25. Glycogen synthase from rabbit skeletal muscle: Effect of insulin on the state of phosphorylation of the seven phosphoserine residues in vivo
26. Glycogen synthase kinase 3 is rapidly inactivated in response to insulin and phosphorylation of eukaryotic initiation factor eIF-2B
27. Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice
28. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription
29. Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphoenolpyruvate carboxykinase gene expression
30. Emerging fundamental themes in modern medicinal chemistry
31. Regulation of the protein kinase activity of Shaggy (Zeste-white3) by components of the wingless pathway in Drosophila cells and embryos
32. Biochemical interactions in the Wnt pathway
33. Differential regulation of glycogen synthase kinase 3β by insulin and Wnt signaling
34. Wnt signaling and cancer
35. GSK3, a master switch regulating cell-fate specification and tumorigenesis
36. Linking colorectal cancer to Wnt signaling
37. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene
38. Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death
39. Formation of protein kinase recognition sites by covalent modification of the substrate. Molecular mechanism for the synergistic action of casein kinase II and glycogen synthase kinase 3
40. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation
41. Crystal structure of glycogen synthase kinase 3b: Structural basis for phosphate-primed substrate specificity and autoinhibition
42. Structure of GSK3β reveals a primed phosphorylation mechanism
43. A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3- catalysed phosphorylation of axin and beta-catenin
44. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway
45. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases
46. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059. SB 203580 also inhibits thromboxane synthase
47. Use of a drug-resistant mutant of stress-activated protein kinase 2a/p38 to validate the in vivo specificity of SB 203580
48. Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution
49. Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP-binding pocket
50. Control of p70, S6 kinase by kinase activity of FRAP in vivo